Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allyn L Mark

Showing results (1-10 of 38) with videos related to

Pageof 4
Sort By:
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Dietary therapy for obesity is a failure and pharmacotherapy is the future: a point of viewAllyn L Mark
Circulation|August 19, 2009
Cardiovascular side effects of antiobesity drugs: a yellow flag in the race to safe pharmacotherapy for obesityAllyn L Mark
Current Hypertension Reports|January 8, 2008
Weight reduction for treatment of obesity-associated hypertension: nuances and challengesAllyn L Mark
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 26, 2013
Selective leptin resistance revisitedAllyn L Mark
Hypertension (Dallas, Tex. : 1979)|May 14, 2008
Dietary therapy for obesity: an emperor with no clothesAllyn L Mark
Hypertension (Dallas, Tex. : 1979)|May 11, 2016
Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic ImplicationsAllyn L Mark, Virend K Somers
Hypertension (Dallas, Tex. : 1979)|January 31, 2013
Björn FolkowGerald F DiBona, Allyn L Mark
Iowa Medicine : Journal of the Iowa Medical Society|October 9, 2002
Ambulatory practice module debuts at Carver College of MedicineKimberly S Ephgrave, Allyn L Mark
Journal of Hypertension|August 27, 2002
Pharmacotherapy of obesity: lessons from clinical trials in hypertensionWilliam G Haynes, Allyn L Mark
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Uncoupling metabolism and coupling leptin to cardiovascular diseaseAllyn L Mark, William I Sivitz
Pageof 4

Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Clinical and Experimental Pharmacology & Physiology|August 23, 2006
Dietary therapy for obesity is a failure and pharmacotherapy is the future: a point of viewAllyn L Mark
Circulation|August 19, 2009
Cardiovascular side effects of antiobesity drugs: a yellow flag in the race to safe pharmacotherapy for obesityAllyn L Mark
Current Hypertension Reports|January 8, 2008
Weight reduction for treatment of obesity-associated hypertension: nuances and challengesAllyn L Mark
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology|July 26, 2013
Selective leptin resistance revisitedAllyn L Mark
Hypertension (Dallas, Tex. : 1979)|May 14, 2008
Dietary therapy for obesity: an emperor with no clothesAllyn L Mark
Hypertension (Dallas, Tex. : 1979)|May 11, 2016
Obesity, Hypoxemia, and Hypertension: Mechanistic Insights and Therapeutic ImplicationsAllyn L Mark, Virend K Somers
Hypertension (Dallas, Tex. : 1979)|January 31, 2013
Björn FolkowGerald F DiBona, Allyn L Mark
Iowa Medicine : Journal of the Iowa Medical Society|October 9, 2002
Ambulatory practice module debuts at Carver College of MedicineKimberly S Ephgrave, Allyn L Mark
Journal of Hypertension|August 27, 2002
Pharmacotherapy of obesity: lessons from clinical trials in hypertensionWilliam G Haynes, Allyn L Mark
Arteriosclerosis, Thrombosis, and Vascular Biology|June 18, 2002
Uncoupling metabolism and coupling leptin to cardiovascular diseaseAllyn L Mark, William I Sivitz
Pageof 4